FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells

Huayuan Liu(Qingdao University), Guangjun Shi(Qingdao University)
Frontiers in Oncology
March 22, 2022
Cited by 32


Related Papers